Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 8/20 | 0.33 |
| ▸ | CNR1 | P21554 | 5/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21074608 | 0.88 | S1PR1 (0.32) | CNR2S1PR3 | |
| SCHEMBL21074601 | 0.85 | FFAR4 (0.38) | THRB | |
| SCHEMBL21074651 | 0.84 | THRB (0.42) | THRBMEN1ALDH1A1KMT2A | |
| SCHEMBL21074600 | 0.82 | CYP2C9 (0.38) | MEN1ALDH1A1KMT2AS1PR3 | |
| SCHEMBL21074598 | 0.82 | SPHK1 (0.41) | THRB | |
| SCHEMBL21074636 | 0.81 | THRB (0.34) | CNR2CNR1THRBMEN1ALDH1A1 | |
| SCHEMBL21074603 | 0.81 | CYP2C9 (0.37) | MEN1ALDH1A1KMT2AS1PR3 | |
| SCHEMBL21074685 | 0.80 | S1PR1 (0.31) | S1PR3 | |
| SCHEMBL21074684 | 0.80 | PPARG (0.32) | THRB | |
| SCHEMBL21074588 | 0.77 | LSS (0.34) | THRBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190169502-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169502-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | PLD1, AP3D1, CCND1 | CNR2 1900/4885CNR1 972/4885THRB 4725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.